Last but not least: bfl-1 as an emerging target for anti-cancer therapies

HIGHLIGHTS

  • who: Biochemical Society Transactions and collaborators from the Department University of Melbourne, Melbourne, VIC, Australia have published the paper: Last but not least: BFL-1 as an emerging target for anti-cancer therapies, in the Journal: (JOURNAL) of 28/07/2022
  • what: With each new vulnerability of cancer targeted and exploited, it seems that new complications emerge.

SUMMARY

    BFL-1 and A1 discovery and function Due to its homology to other BCL-2 family genes, and its overexpression in clinical samples of stomach cancer, BFL-1 was hypothesised to promote cell . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?